Patents by Inventor Hermann Kollmann

Hermann Kollmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220332728
    Abstract: A compound of compound according to formula (I): wherein X is selected from the group consisting of CH, CCl and N, Z is selected from the group consisting of CH2COOH, CH(CH3)COOH, C(CH3)2COOH and CH2F, D is a single bond connecting A and Ar or selected from the group consisting of CO, NHCO and N(C0-6)alkyl-CO, A is selected from the group consisting of a (C1-6)alkanediyl and a (C3-6)cycloalkanediyl or, if D is N(C0)alkyl-CO, A forms a 4- to 7-membered aliphatic heterocyclic ring with the nitrogen atom of N(C0)alkyl-CO in D, and Ar is a 6-membered aromatic ring with a first hydroxyl group in para-position to D, a second hydroxyl group in meta-position to D, and with at least one electron-withdrawing element and uses thereof.
    Type: Application
    Filed: September 4, 2020
    Publication date: October 20, 2022
    Inventors: Rosemarie Riedl, Susanne Paukner, Wolfgang Wicha, Josef Wieser, Klaus Thirring, Hermann Kollmann
  • Patent number: 9701628
    Abstract: A compound selected from 14-O-[((Alkyl-, cycloalkyl-, heterocycloalkyl-, heteoroaryl-, or aryl)-sulfanyl)-acetyl]-12-epi-mutilins, or 14-O-[((Alkyl-, cycloalkyl-, heterocycloalkyl-, heteoroaryl-, or aryl)-oxy)-acetyl]-12-epi-mutilins, wherein 12-epi-mutilin is characterized in that the mutilin ring at position 12 is substituted by two substituents, the first substituent at position 12 of the mutilin ring is a methyl group which methyl group has the inverse stereochemistry compared with the stereochemistry of the methyl group at position 12 of the naturally occurring pleuromutilin ring, the second substituent at position 12 of the mutilin ring is a hydrocarbon group comprising at least one nitrogen atom and all other substituents of the mutilin ring having the same stereochemistry compared with the stereochemistry of the substituents at the corresponding positions in the naturally occurring pleuromutilin ring; optionally in the form of a salt and/or solvate, wherein the naturally occurring pleuromutilin is of
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: July 11, 2017
    Assignee: Nabriva Therapeutics AG
    Inventors: Klaus Thirring, Werner Heilmayer, Rosemarie Riedl, Hermann Kollmann, Zrinka Ivezic-Schoenfeld, Wolfgang Wicha, Susanne Paukner, Dirk Strickmann
  • Publication number: 20160332963
    Abstract: A compound selected from 14-O-[((Alkyl-, cycloalkyl-, heterocycloalkyl-, heteoroaryl-, or aryl)-sulfanyl)-acetyl]-12-epi-mutilins, or 14-O-[((Alkyl-, cycloalkyl-, heterocycloalkyl-, heteoroaryl-, or aryl)-oxy)-acetyl]-12-epi-mutilins, wherein 12-epi-mutilin is characterized in that the mutilin ring at position 12 is substituted by two substituents, the first substituent at position 12 of the mutilin ring is a methyl group which methyl group has the inverse stereochemistry compared with the stereochemistry of the methyl group at position 12 of the naturally occurring pleuromutilin ring, the second substituent at position 12 of the mutilin ring is a hydrocarbon group comprising at least one nitrogen atom and all other substituents of the mutilin ring having the same stereochemistry compared with the stereochemistry of the substituents at the corresponding positions in the naturally occurring pleuromutilin ring; optionally in the form of a salt and/or solvate, wherein the naturally occurring pleuromutilin is of
    Type: Application
    Filed: January 21, 2015
    Publication date: November 17, 2016
    Inventors: Klaus Thirring, Werner Heilmayer, Rosemarie Riedl, Hermann Kollmann, Zrinka Ivezic-Schoenfeld, Wolfgang Wicha, Susanne Paukner, Dirk Strickmann
  • Publication number: 20080249119
    Abstract: The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1, method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative diseases. The invention further relates to novel intermediates, as used in the inventive method.
    Type: Application
    Filed: July 20, 2006
    Publication date: October 9, 2008
    Applicant: PHARMACON-FORSCHUNG UND BERATUNG GMBH
    Inventors: Christian R. Noe, Muhamed Jasic, Hermann Kollmann, Karmin Saadat
  • Publication number: 20080221340
    Abstract: The subject of the invention is a process for the production of the racemic active ingredient nebivolol, in which diastereomeric cyanohydrins are produced, separated, and the separated diastereomers are coupled to one another after a transformation, preferably a partial or complete reduction of the cyano group or a Pinner saponification.
    Type: Application
    Filed: July 17, 2006
    Publication date: September 11, 2008
    Applicant: Pharmacon Forschung und Bearatung GmbH
    Inventors: Christian R. Noe, Muhamed Jasic, Hermann Kollmann, Bodo Lachmann
  • Patent number: 6124298
    Abstract: The present invention relates to novel pyrazine compounds and their use in the regulation of haematopoiesis, in particular in the stimulation of haematopoiesis, and in the treatment of bacterial, viral and fungal diseases.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: September 26, 2000
    Assignee: Nycomed Imaging AS
    Inventors: Jessie Sandosham, Johann Hiebl, Hermann Kollmann, Alan Cuthbertson, Peter Fischer, Michael Hartmann, Peter Kremminger, Franz Rovenszky, Mette Husbyn
  • Patent number: 5972926
    Abstract: The present invention relates to pyrazine fused to a cyclic peptide which is capable of regulating, in particular stimulating, haematopoiesis.
    Type: Grant
    Filed: June 5, 1998
    Date of Patent: October 26, 1999
    Assignee: Nycomed Imaging AS
    Inventors: Jessie Sandosham, Johann Hiebl, Hermann Kollmann, Alan Cuthbertson, Peter Fischer, Michael Hartmann, Peter Kremminger, Franz Rovenszky, Mette Husbyn
  • Patent number: 5257588
    Abstract: The invention relates to a method of flue gas abatement for a combustion process, particularly for a refuse incinerating unit, in the case of which ammonia in a gaseous form or dissolved in water is fed into the combustion process or hot flue gases therefrom and furthermore preferably acidic components are removed by scrubbing from the flue gases and are neutralized by a basic material, to which milk of lime has been added, and furthermore the flue gases may be passed in addition though adsorbing materials and if necessary basic materials are supplied to the process so that nitrogen oxides, hydrogen chloride in gas form, dioxines and furans are removed. The material necessary for this are taken from a local sewage plant where they at least proportionately form partial streams in a sludge treatment unit and otherwise would have to be dispensed with.
    Type: Grant
    Filed: January 29, 1992
    Date of Patent: November 2, 1993
    Inventor: Hermann Kollmann